Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is -48.31% vs 142.65% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -61.81% vs 2,343.75% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is -55.10% vs 235.83% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 100.00% vs -25.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of Ligand Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is -48.31% vs 142.65% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 39.49% vs 52.31% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -61.81% vs 2,343.75% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 244.05% vs -270.88% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is -55.10% vs 235.83% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 158.72% vs 78.69% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 100.00% vs -25.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 100.00% vs 800.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






